Emerging Technology

Wearables have great potential to continue advancing research in Rett syndrome as well as other rare disease areas.

How artificial intelligence can aid in selecting patients, leveraging safety insights, and optimizing combination therapies.

Despite limitations to its widespread use within healthcare, there is great potential for ChatGPT’s application in drug development.

Panna Sharma, CEO of Lantern Pharma, discusses LP-284, using their RADR during testing, ensuring global use, and what the future holds.

A survey conducted at this year’s Pistoia Alliance conference determined that although 70% of life sciences experts acknowledge artificial intelligence’s potential, many still struggle with its initiation and implementation.

Despite the significance offered by AI to pharmaceutical companies, there are several challenges that must be overcome for successful integration of tech-based tools.